The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
about
Bench-to-bedside translation of magnetic nanoparticlesSimultaneous steering and imaging of magnetic particles using MRI toward delivery of therapeuticsNanomedicine as a strategy to fight thrombotic diseases.Tissue plasminogen activator-based clot busting: Controlled delivery approachesA biological perspective toward the interaction of theranostic nanoparticles with the bloodstream - what needs to be considered?Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer.Visible Thrombolysis Acceleration of a Nanomachine Powered by Light-Driving F0F1-ATPase Motor.Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention.Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.The effect of N-alkyl substituents on the usability of imidazolium cation-based ionic liquids in microemulsion systems: a technical note.Magnetic nanoparticles for targeted vascular delivery.Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.Engineered nanoparticles: thrombotic events in cancer.Nanodevices for the immobilization of therapeutic enzymes.Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.Translational initiatives in thrombolytic therapy.Optimal Halbach Permanent Magnet Designs for Maximally Pulling and Pushing Nanoparticles.Synthesis of brightly PEGylated luminescent magnetic upconversion nanophosphors for deep tissue and dual MRI imaging.Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.Uniform magnetic targeting of magnetic particles attracted by a new ferromagnetic biological patch.Nanoparticle mediated cell capture enables rapid endothelialization of a novel bare metal stent.Membrane protein isolation and identification by covalent binding for proteome research.Magnetizable stent-grafts enable endothelial cell capture.Design and validation of a novel ferromagnetic bare metal stent capable of capturing and retaining endothelial cells.Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysisDelivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage
P2860
Q26850547-9672BD68-4D1A-44F9-822D-F9CB9E3A1495Q27347696-38DBDDBC-7A49-4BFF-AF81-88BB2EE8CCD0Q30367197-06729744-300C-45A5-802F-2D158A1C9EABQ30416699-F0739B18-DBA1-4B4D-A261-A00025F6D050Q35067441-09C7A07D-E964-463B-A557-E283684B1DC1Q35558902-8615A617-5AC0-4CC3-AF9C-993EA4D57221Q35661594-AF062908-F48B-48F8-98CF-C96D1BCCFD5FQ36295006-B6F26EB6-4F97-451B-864B-F07231D17C01Q36408215-8B7AA76F-CE64-4672-9316-6E0381F3C2F7Q36479606-6A10AC89-1A29-4F84-A1F9-9EEDBA4DEE59Q36882114-0494753F-C2F1-4974-A9A8-912F6ED9F1C8Q37896554-12B2BC08-7657-482E-84E2-5D41C650614FQ38034502-DC6C4912-5C95-4FAA-87F9-BAEEDB09CCF8Q38262939-3427714B-A74A-4B1B-AD4E-D220704E8D72Q38340160-CB180EB8-B785-4F30-8F1C-6A8E94410D29Q38527633-521250E3-0CDF-4002-A6AE-2AAB699ADD2AQ38696169-008A7219-0289-45EB-ADF3-6A585D735E21Q38830237-4C549560-A78A-4AE4-9007-37CD566C666CQ39100187-CD021EDD-585E-4CB5-B7EC-D255AE6B8EB8Q42181688-3D7C1C2D-FA77-49B2-AA51-0C508F2D036FQ42763346-8891754C-61DA-41E8-9074-B84104B5D103Q44949624-F85E15FE-E1A0-4BA7-BAD5-EA9727B1D001Q47589446-B380520E-A643-4B7C-87CA-81CE7A5BCCCBQ47931181-38E09664-F8D2-43CA-A8A5-109F7FE1B1F1Q48159250-23BDCEDF-0F76-48F6-ABFA-809C0D451600Q49687127-75966BF5-B015-4D1F-92FF-AA4E7365AA06Q50069843-28E1575B-0C05-443E-9643-8E4D48FA1BBCQ50934876-140E95F2-8130-4CAF-BDD6-EB7DF4EC95C4Q50962192-56DAA92C-411B-46D5-934A-C1599EC7E4E7Q51062205-0A2F57A9-F044-458A-A32F-23CB36A3F7FDQ53280432-8866C528-1C19-4744-A079-07C113F6D37FQ53589220-3CEBF040-8280-4F56-85E5-E49EEEF820E4Q57377087-2ABA3834-2AC3-46E7-B005-19DB1655CC43Q57377620-F35BC01C-7BE2-47BA-B484-D682BFC4A89C
P2860
The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@ast
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@en
type
label
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@ast
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@en
prefLabel
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@ast
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@en
P2093
P921
P1433
P1476
The use of magnetite nanoparti ...... eting in thrombolytic therapy.
@en
P2093
Carlos Rodriguez Arza
Henrik Kempe
Ian Snowball
Maria Kempe
Matthias Götberg
Rita Wallén
Tommy Olsson
P304
P356
10.1016/J.BIOMATERIALS.2010.07.107
P577
2010-08-21T00:00:00Z